Shattuck Labs, Inc. (STTK) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
22/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSTTK / S&P 7.93% / 15.20% |
LoseSTTK / S&P -66.63% / 15.00% |
LoseSTTK / S&P -61.16% / 50.40% |
| 2026-Q11/3 |
WinSTTK / S&P 76.16% / -4.33% |
LoseSTTK / S&P -78.29% / 11.30% |
LoseSTTK / S&P -57.55% / 27.70% |
| 2025-Q41/3 |
WinSTTK / S&P 52.72% / 2.65% |
LoseSTTK / S&P -82.52% / 9.00% |
LoseSTTK / S&P -51.01% / 13.40% |
| 2025-Q31/3 |
WinSTTK / S&P 201.77% / 8.12% |
LoseSTTK / S&P -84.46% / 4.61% |
LoseSTTK / S&P -33.33% / 13.45% |
| 2025-Q20/3 |
LoseSTTK / S&P -16.63% / 10.94% |
LoseSTTK / S&P -27.33% / 4.83% |
LoseSTTK / S&P -34.59% / 10.63% |
| 2025-Q11/3 |
LoseSTTK / S&P -21.49% / -4.27% |
WinSTTK / S&P 69.65% / 4.98% |
LoseSTTK / S&P -27.98% / 10.57% |
| 2024-Q41/3 |
LoseSTTK / S&P -65.33% / 2.41% |
WinSTTK / S&P 245.26% / 5.25% |
LoseSTTK / S&P -27.32% / 6.15% |
| 2024-Q31/3 |
LoseSTTK / S&P -9.59% / 5.89% |
WinSTTK / S&P 382.75% / 5.89% |
LoseSTTK / S&P -31.70% / 6.11% |
| 2024-Q21/3 |
LoseSTTK / S&P -56.82% / 4.28% |
WinSTTK / S&P 380.09% / 5.38% |
LoseSTTK / S&P -14.75% / 5.12% |
| 2024-Q12/3 |
WinSTTK / S&P 25.39% / 10.56% |
WinSTTK / S&P 282.93% / 5.71% |
LoseSTTK / S&P -16.81% / 5.59% |
| 2023-Q42/3 |
WinSTTK / S&P 369.08% / 11.69% |
WinSTTK / S&P 154.14% / 6.81% |
LoseSTTK / S&P -14.94% / 7.78% |
| 2023-Q31/3 |
LoseSTTK / S&P -51.28% / -3.27% |
LoseSTTK / S&P -95.61% / 7.52% |
WinSTTK / S&P 38.27% / -5.03% |
| 2023-Q21/3 |
LoseSTTK / S&P 6.12% / 8.74% |
LoseSTTK / S&P -97.32% / 9.50% |
WinSTTK / S&P 49.66% / -8.57% |
| 2023-Q12/3 |
WinSTTK / S&P 27.83% / 7.50% |
LoseSTTK / S&P -97.44% / 10.77% |
WinSTTK / S&P 70.59% / -15.69% |
| 2022-Q41/3 |
LoseSTTK / S&P -14.81% / 7.56% |
LoseSTTK / S&P -97.83% / 11.88% |
WinSTTK / S&P 127.36% / -17.99% |
| 2022-Q32/3 |
LoseSTTK / S&P -33.50% / -4.88% |
WinSTTK / S&P 2268.46% / 13.47% |
WinSTTK / S&P 305.00% / -1.41% |
| 2022-Q22/3 |
WinSTTK / S&P -4.69% / -16.10% |
WinSTTK / S&P 1663.66% / 13.71% |
LoseSTTK / S&P -5.23% / 11.04% |
| 2022-Q11/3 |
LoseSTTK / S&P -49.94% / -4.60% |
WinSTTK / S&P 200.68% / 15.97% |
LoseSTTK / S&P -23.60% / 42.23% |
| 2021-Q41/3 |
LoseSTTK / S&P -58.24% / 11.03% |
WinSTTK / S&P 202.16% / 15.00% |
LoseSTTK / S&P STTK unavailable / 96.40% |
| 2021-Q30/3 |
LoseSTTK / S&P -29.70% / 0.58% |
LoseSTTK / S&P -88.78% / 10.77% |
LoseSTTK / S&P STTK unavailable / 69.42% |
| 2021-Q20/3 |
LoseSTTK / S&P -0.85% / 8.55% |
LoseSTTK / S&P -83.13% / 6.58% |
LoseSTTK / S&P STTK unavailable / 51.81% |
| 2021-Q10/3 |
LoseSTTK / S&P -44.21% / 6.17% |
LoseSTTK / S&P STTK unavailable / -1.06% |
LoseSTTK / S&P STTK unavailable / 7.39% |
| 2020-Q40/3 |
LoseSTTK / S&P STTK unavailable / 12.15% |
LoseSTTK / S&P STTK unavailable / -3.72% |
LoseSTTK / S&P STTK unavailable / -33.42% |
| 2020-Q30/3 |
LoseSTTK / S&P STTK unavailable / 8.93% |
LoseSTTK / S&P STTK unavailable / -2.04% |
LoseSTTK / S&P STTK unavailable / -27.10% |
| 2020-Q20/3 |
LoseSTTK / S&P STTK unavailable / 20.54% |
LoseSTTK / S&P STTK unavailable / -0.46% |
LoseSTTK / S&P STTK unavailable / -27.11% |
| 2020-Q10/3 |
LoseSTTK / S&P STTK unavailable / -19.60% |
LoseSTTK / S&P STTK unavailable / 3.47% |
LoseSTTK / S&P STTK unavailable / -14.75% |
| 2019-Q40/3 |
LoseSTTK / S&P STTK unavailable / 9.07% |
LoseSTTK / S&P STTK unavailable / 5.36% |
LoseSTTK / S&P STTK unavailable / 2.99% |
| 2019-Q30/3 |
LoseSTTK / S&P STTK unavailable / 1.70% |
LoseSTTK / S&P STTK unavailable / 5.02% |
LoseSTTK / S&P STTK unavailable / 0.21% |
| 2019-Q20/3 |
LoseSTTK / S&P STTK unavailable / 4.30% |
LoseSTTK / S&P STTK unavailable / 6.64% |
LoseSTTK / S&P STTK unavailable / 8.65% |
| 2019-Q10/3 |
LoseSTTK / S&P STTK unavailable / 13.65% |
LoseSTTK / S&P STTK unavailable / 8.12% |
LoseSTTK / S&P STTK unavailable / 14.29% |
| 2018-Q40/3 |
LoseSTTK / S&P STTK unavailable / -13.52% |
LoseSTTK / S&P STTK unavailable / 9.05% |
LoseSTTK / S&P STTK unavailable / 18.23% |
| 2018-Q30/3 |
LoseSTTK / S&P STTK unavailable / 7.71% |
LoseSTTK / S&P STTK unavailable / 10.21% |
LoseSTTK / S&P STTK unavailable / 19.06% |
| 2018-Q20/3 |
LoseSTTK / S&P STTK unavailable / 3.43% |
LoseSTTK / S&P STTK unavailable / 9.03% |
LoseSTTK / S&P STTK unavailable / 14.46% |
| 2018-Q10/3 |
LoseSTTK / S&P STTK unavailable / -0.76% |
LoseSTTK / S&P STTK unavailable / 7.68% |
LoseSTTK / S&P STTK unavailable / 12.46% |
| 2017-Q40/3 |
LoseSTTK / S&P STTK unavailable / 6.64% |
LoseSTTK / S&P STTK unavailable / 7.03% |
LoseSTTK / S&P STTK unavailable / 13.82% |
| 2017-Q30/3 |
LoseSTTK / S&P STTK unavailable / 4.48% |
LoseSTTK / S&P STTK unavailable / 5.68% |
LoseSTTK / S&P STTK unavailable / 17.57% |
| 2017-Q20/3 |
LoseSTTK / S&P STTK unavailable / 3.09% |
LoseSTTK / S&P STTK unavailable / 4.83% |
LoseSTTK / S&P STTK unavailable / 17.74% |
| 2017-Q10/3 |
LoseSTTK / S&P STTK unavailable / 6.07% |
LoseSTTK / S&P STTK unavailable / 3.67% |
LoseSTTK / S&P STTK unavailable / 13.32% |
| 2016-Q40/3 |
LoseSTTK / S&P STTK unavailable / 3.82% |
LoseSTTK / S&P STTK unavailable / 2.09% |
LoseSTTK / S&P STTK unavailable / 7.05% |
| 2016-Q30/3 |
LoseSTTK / S&P STTK unavailable / 3.85% |
LoseSTTK / S&P STTK unavailable / 0.20% |
LoseSTTK / S&P STTK unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | STTK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 679.82% | 20.78% |
| Annualized return | 679.82% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | STTK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -64.40% | 83.14% |
| Annualized return | -18.66% | 12.86% |
10Y · 2020-10-09 to 2026-08-27
| Metric | STTK total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -60.47% | 319.30% |
| Annualized return | -8.86% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |